Michael Ayers

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

First Posted Date
2023-09-05
Last Posted Date
2024-11-06
Lead Sponsor
Michael Ayers
Target Recruit Count
20
Registration Number
NCT06023186
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

© Copyright 2024. All Rights Reserved by MedPath